Palvella Therapeutics Sees Massive Price Target Hike Following Promising Clinical Outlook
Investors in the biotechnology sector are closely watching Palvella Therapeutics this week as market sentiment shifts dramatically in favor of the clinical-stage
by 
Josh Weiner
Josh Weiner